| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |